About PathogenDX
PathogenDX is a company based in Tucson (United States) founded in 2014 by Eric Lachance and Michael Hogan.. PathogenDX has raised $11.58 million across 5 funding rounds from investors including NIH, HHS and Entourage Effect Capital. The company has 31 employees as of December 31, 2021. PathogenDX offers products and services including D3 Array™, Octa™ AutoPrep Station, and Sero X Assay. PathogenDX operates in a competitive market with competitors including Inflammatix, Agendia, GenomeDx Biosciences, Akonni and KromaTiD, among others.
- Headquarter Tucson, United States
- Employees 31 as on 31 Dec, 2021
- Founders Eric Lachance, Michael Hogan
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pathogendx, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.58 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
NIH
& 7 more
-
Employee Count
31
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PathogenDX
PathogenDX offers a comprehensive portfolio of products and services, including D3 Array™, Octa™ AutoPrep Station, and Sero X Assay. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid multiplexed pathogen detection for clinical and food use
Automates lab workflows for cannabis pathogen testing
Detects Salmonella serotypes in food processing
Unlock access to complete
Unlock access to complete
Funding Insights of PathogenDX
PathogenDX has successfully raised a total of $11.58M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(19 Apr 2016)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Grant - PathogenDX | Valuation |
investors |
|
| Aug, 2020 | Amount | Grant - PathogenDX | Valuation |
investors |
|
| Sep, 2019 | Amount | Series B - PathogenDX | Valuation | Entourage Effect Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PathogenDX
PathogenDX has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Entourage Effect Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment firm focused on cannabis industry growth and leadership.
|
Founded Year | Domain | Location | |
|
Investments are focused on the emerging global cannabis industry.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PathogenDX
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PathogenDX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pathogendx Comparisons
Competitors of PathogenDX
PathogenDX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, Agendia, GenomeDx Biosciences, Akonni and KromaTiD, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Genomic diagnostic products for cancer treatment are provided.
|
|
| domain | founded_year | HQ Location |
Genomic tests for urologic cancers are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostics for complex infections are developed by Akonni.
|
|
| domain | founded_year | HQ Location |
Molecular and genetic tests for detecting disease-causing mutations are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pathogendx
Frequently Asked Questions about PathogenDX
When was PathogenDX founded?
PathogenDX was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is PathogenDX located?
PathogenDX is headquartered in Tucson, United States. It is registered at Tucson, Arizona, United States.
Is PathogenDX a funded company?
PathogenDX is a funded company, having raised a total of $11.58M across 5 funding rounds to date. The company's 1st funding round was a Series B of $7.5M, raised on Apr 19, 2016.
How many employees does PathogenDX have?
As of Dec 31, 2021, the latest employee count at PathogenDX is 31.
What does PathogenDX do?
PathogenDX was founded in 2014 and is based in Tucson, United States. DNA-based testing kits for pathogen detection are offered by the company to the botanicals, food, and agriculture industries. Operations center on microbial testing services, including those for cannabis and botanical applications, with a focus on supporting safety and quality assessments in these sectors.
Who are the top competitors of PathogenDX?
PathogenDX's top competitors include Inflammatix, Agendia and KromaTiD.
What products or services does PathogenDX offer?
PathogenDX offers D3 Array™, Octa™ AutoPrep Station, and Sero X Assay.
Who are PathogenDX's investors?
PathogenDX has 8 investors. Key investors include NIH, HHS, Entourage Effect Capital, Altitude Investment Management, and Arcadian Investment Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.